In the present study, we investigated the effect of long-acyl chain SFA, namely palmitic acid (16 : 0) and stearic acid (18 : 0), at sn-1, 3 positions of TAG on obesity. Throughout the 15 weeks of the experimental period, C57BL/6 mice were fed diets fortified with cocoa butter, sal stearin (SAL), palm mid fraction (PMF) and high-oleic sunflower oil (HOS). The sn-1, 3 positions were varied by 16 : 0, 18 : 0 and 18 : 1, whilst the sn-2 position was preserved with 18 : 1. The HOS-enriched diet was found to lead to the highest fat deposition. This was in accordance with our previous postulation. Upon normalisation of total fat deposited with food intake to obtain the fat:feed ratio, interestingly, mice fed the SAL-enriched diet exhibited significantly lower visceral fat/feed and total fat/feed compared with those fed the PMF-enriched diet, despite their similarity in SFA -unsaturated fatty acid-SFA profile. That long-chain SFA at sn-1, 3 positions concomitantly with an unsaturated FA at the sn-2 position exert an obesity-reducing effect was further validated. The present study is the first of its kind to demonstrate that SFA of different chain lengths at sn-1, 3 positions exert profound effects on fat accretion.
Obesity is a cardiovascular risk factor that is also associated with a substantial increase in the risk of type 2 diabetes, hypertension and lipoprotein metabolism disorders. Concerted efforts have been made to establish the relationship between obesity and lipid intake; yet, most of the studies are merely based on the total SFA (1 -4) , total unsaturated fatty acid (1 -5) , MUFA (3) , n-6 PUFA (3,6 -9) and n-3 PUFA (8,10 -12) contents of edible oils. In general, a high-SFA-rich diet is perceived to be more obesogenic than diets with lower saturated contents (1 -3) . However, it has been reported that cocoa butter (COB), a typical saturated fat that contains 63 g SFA/100 g total fatty acids, causes less weight gain when compared with safflower and olive oils (4) . A study carried out by Matsuo et al. (3) has shown positive correlations of carcass fat content with palmitic, stearic and oleic acids and a negative correlation with linoleic acid in rats. Thus, an excessive intake of MUFA is also postulated to exert detrimental effects on adiposity (3) . There has been some controversy regarding the effect of n-6 PUFA, in particular, linoleic acid, on obesity. In recent studies, linoleic acid has been reported to exert pro-obesity effects using rodents (5, 6) ; notwithstanding this, some researchers have postulated n-6 PUFA to be most effective at limiting fat accretion (3, 7, 8) . A recent review article has disclosed that the role of n-6 PUFA in obesity remains vague as no conclusive inference can be drawn from the available epidemiological evidence (9) . Additionally, n-3 PUFA (10, 11) have also been claimed to reduce fat deposition; yet, no definite results could be obtained by a systematic review evaluating the effect of n-3 PUFA on body-mass gain (12) . It is evident that the reported results contradict each other. Moreover, there is a paucity of information regarding the positional fatty acids of TAG and their associated effects on obesity.
Kojima et al. (13) reported that dietary 1(3)-behenoyl-2, 3(1)-dioleoylglycerol, which contains long-chain saturated behenic acid (22 : 0) at sn-1 or sn-3 position, prevents visceral fat deposition. Our recent in vivo study has also revealed that long-chain SFA tend to reduce fat deposition if present at sn-1 and sn-3 positions (14) . An exceptional direct negative correlation has been found between fat/feed and total SFA content at sn-1, 3 positions (14) . If long-chain SFA are present at sn-1, 3 positions, they might not be readily absorbed upon hydrolysis due to the formation of Ca soaps and consequently enter the distal gut and colon, where they are excreted (15, 16) . Prior literature has disclosed that the excretion of SFA is also directly related to their chain lengths (13) . Henceforth, we hypothesised that further alleviation of fat deposition might occur if stearic acids rather than palmitic and oleic acids are mainly present at sn-1, 3 positions. In the present study, the effect of common long-chain SFA, namely palmitic acid (16 : 0) and stearic acid (18 : 0), at sn-1, 3 positions of TAG on obesity was investigated using COB, sal stearin (SAL), palm mid fraction (PMF) and high-oleic sunflower oil (HOS). Feed efficiency in terms of fat deposition, i.e. fat/ feed, was determined to accurately interpret the diet-induced adipogenic effects of the test oils.
Materials and methods

Diet
Autoclavable standard pellet feeds (digestible energy 14·0 MJ/kg) were purchased from Specialty Feeds. The nutrient composition of the autoclavable standard pellet feeds is given in the Supplementary material (available online). Refined, bleached and deodorised SAL, also known as Shorea robusta, was a gift from Mewah Oil Sdn. Bhd. Refined, bleached and deodorised COB, PMF and HOS were obtained from Intercontinental Specialty Fats Sdn. Bhd. The total and positional fatty acid compositions of dietary oils are given in Tables 1  and 2 , respectively. The diets were prepared by fortifying the standard pellet feeds with the test oils at a composition of 150 g/kg diet; subsequently, the mixtures were pelleted into original shape. These diets were left to dry at 308C overnight before being fed to the mice. All the test diets were isoenergetic (20 MJ/kg; 60 % of energy from fat).
Animals
A total of forty weaned male C57BL/6 mice were obtained from Monash University. The mice were acclimatised to the environmentally controlled laboratory environment (23^28C and a relative humidity of 60 %) under a 12 h light -12 h dark cycle. Subsequently, they were randomly divided into four groups of ten mice each and housed individually. The average body masses of the mice did not differ significantly after randomisation (P¼0·089) and were 19·7 (SD 0·9), 19·9 (SD 1·2), 20·3 (SD 0·7) and 19·7 (SD 1·2) g for the COB, SAL, PMF and HOS dietary groups, respectively. Throughout the 15 weeks of the experimental period, the mice were given ad libitum access to water and food. Food intake was determined on a daily basis, whereas the body mass of the mice was recorded weekly. The actual food intake was corrected for spilled food after separating it from the faeces of the mice. Fresh faecal samples were collected daily and stored at 2208C. The mice were killed by dislocation of the neck. The subcutaneous and visceral adipose tissues were removed from the carcasses, weighed and kept frozen at 2 808C. The relative amount of total fat is expressed as the fat mass percentage in mouse carcass. Data on body-mass gain and mass of fat deposited were subjected to normalisation with total food intake, shorthanded as gain/feed and fat/feed, respectively. All the protocols followed in the in vivo study were approved by the Animal Care and Use Committee, University of Malaya, Kuala Lumpur, Malaysia (ethic no: KIM/22/11/ 2011/GSW (R)).
Lipid analysis
The extraction and isolation of lipids from adipose tissue and faecal samples were carried out in accordance with a modified method (17) . The analyses of total fatty acid compositions of the test oils and faecal lipids were carried out in accordance with earlier work (14) . The composition ratio of major NEFA in faeces:individual fatty acids in the test oils was computed to represent the excretion index of each fatty acid. Regiospecific analyses of the test oils and adipose tissue samples were carried out using a JEOL ECA-400 MHz NMR spectrometer (JEOL Ltd) as reported previously (18) . Faecal fatty acids were derivatised, and their absolute amounts were ascertained by GC according to the method of Cheng et al. (19) .
Statistical analyses
All the statistical analyses were carried out using IBM SPSS Statistic 20 (SPSS Inc.). One-way ANOVA was used to assess the significance of differences among the dietary groups, whereas Tukey's honestly significant difference test was used for pairwise comparisons. P values lower than 0·05 were considered significant.
Results
Food intake, body-mass gain and body-mass gain/g of feed
All the mice exhibited comparable total food intake (P¼0·400) throughout the experimental period. Food intake on a weekly basis is given in the Supplementary material (available online).
Mice fed the HOS-enriched diet gained significantly higher body mass when compared with those fed the COB-enriched (P¼ 0·030) and SAL-enriched (P,0·001) diets (Table 3) . Mice fed the SAL-enriched diet also exhibited significantly lower (P¼ 0·023) body-mass gain when compared with those fed the PMF-enriched diet (Table 3) . Normalised data indicated significantly lower gain/feed in the COB (P¼ 0·002) and SAL (P,0·001) dietary groups than in the HOS dietary group. In addition, mice fed the PMF-enriched diet had significantly higher gain/feed (P¼0·003) compared with those fed the SAL-enriched diet (Table 3) .
Fat deposition
Mice in the HOS dietary group exhibited significantly higher subcutaneous fat mass when compared with those in the COB (P¼ 0·004), SAL (P, 0·001) and PMF (P¼0·029) dietary groups (Table 3) . Furthermore, the percentage of visceral fat was significantly lower in mice fed the SAL-enriched diet than in those fed the PMF-enriched (P¼0·041) and HOS-enriched (P¼ 0·010) diets. Overall, the HOS dietary group exhibited significantly higher total fat deposition when compared with the COB (P¼0·017) and SAL (P¼0·001) dietary groups. With respect to the relative amount of total fat contributing to the final body mass, mice in the HOS dietary group exhibited a significantly higher percentage of subcutaneous fat compared with those in the COB (P¼0·008), SAL (P,0·001) and PMF (P¼ 0·036) dietary groups. Furthermore, mice in the SAL dietary group displayed a significantly lower percentage of visceral fat (P¼ 0·035) compared with those in the HOS dietary group. With respect to the relative amount of total fat in the carcass, mice fed the HOS-enriched diet exhibited a significantly higher percentage compared with those fed the SAL-enriched (P¼0·002) and COB-enriched (P¼0·041) diets.
The mass of fat deposited was further subjected to normalisation with total food intake, shorthanded as fat/feed. COB, cocoa butter; SAL, sal stearin; PMF, palm mid fraction; HOS, high-oleic sunflower oil. a,b,c Mean values within a row with unlike superscript letters were significantly different (P, 0·05). * P values were determined by one-way ANOVA. † Food intake was calculated as the total food intake for each mouse in 15 weeks and then averaged for each group (n 10).
Subcutaneous fat/feed (Table 3 ) of the HOS dietary group was significantly higher than that of the COB (P¼ 0·001), SAL (P,0·001) and PMF (P¼0·016) dietary groups. The values of visceral fat/feed and total fat/feed were significantly lower in the SAL (P¼0·007 and P,0·001, respectively) and COB (P¼0·043 and P¼0·006, respectively) dietary groups than in the HOS dietary group. Furthermore, mice fed the PMF-enriched diet continued to exhibit significantly higher visceral fat/feed (P¼ 0·029) compared with those fed the SAL-enriched diet (Table 3) . It is worth noting that significantly lower amounts (P¼0·037) of total fat deposited per g of feed consumed were observed in the SAL dietary group than in the PMF dietary group. On the other hand, the COB dietary group exhibited non-significant differences for all the parameters when compared with both the SAL and PMF dietary groups.
As shown in Fig. 1 , a poor correlation was observed between feed efficiency (fat/feed) and total SFA content at sn-1, 3 positions of TAG in dietary fats (r 0·6847 -0·9195). Correlation coefficients for all the parameters were nonsignificant, as the resultant P values were greater than 0·05. Nevertheless, when fat/feed was plotted against stearic acid content at sn-1, 3 positions, negative linear correlations were observed for subcutaneous fat/feed, visceral fat/feed and total fat/feed (r 0·9693, 0·9989 and 0·9999, respectively) (Fig. 2) . Correlation coefficients for both total fat/feed and visceral fat/feed against stearic acid content at sn-1, 3 positions were found to be statistically significant at P values of 0·011 and 0·030, respectively.
Faecal fatty acids
The lipid fraction of mouse faeces mainly contained NEFA, while TAG and other partial acylglycerols remained undetected. The composition of faecal NEFA of each dietary group is given in the Supplementary material (available online). With respect to the absolute amount of faecal fatty acids excreted (Table 4) , the SAL dietary group excreted significantly higher amounts of NEFA than the COB (P¼ 0·038), PMF (P¼0·031) and HOS (P¼ 0·002) dietary groups. Among the four dietary groups, the HOS dietary group excreted the lowest amounts of faecal NEFA (Table 4) .
The excretion index denotes the relationship between faecal fatty acids and their corresponding composition in the ingested fats ( Table 5 ). The most abundant MUFA, namely oleic acid, is most readily absorbed, as the excretion indices fall in the range of 0·28 -0·60. In other words, the relative composition of oleic acid in faeces is lower than that in dietary fats. On the contrary, the major SFA, namely palmitic and stearic acids, are relatively more readily excreted, as their excretion indices are greater than unity. Greater excretion indices were observed for stearic acid (1·32-3·87) than for palmitic acid (1·15-3·33) in all the dietary groups ( Table 5) .
Discussion
In the present study, C57BL/6 mice were employed as this strain has been reported to be a robust and efficient animal model for human obesity and type 2 diabetes as well as to remain lean if the fat content of the diet is limited (20 -22) . Most of the animal models do not fulfil these requirements, as they are mainly based on monogenic disorders of limited relevance to human obesity and diabetes. Moreover, C57BL/6 mice exhibit intact leptin signalling and display delayed-onset obesity that can be amplified in response to high-fat diets, making them an ideal model for human obesity studies (23) . In addition, this mouse model has a genetic factor similar to that of humans that causes diabetes after the development of obesity (20) . The major TAG present in the test oils, namely COB, SAL, PMF and HOS, used in the present study were 1-palmitoyl-2-oleoyl-3-stearoyl glycerol (POSt), 1,3-distearoyl-2-oleoyl glycerol (StOSt), 1,3-dipalmitoyl-2-oleoylglycerol and trioleoylglycerol, respectively (24) . In an effort to examine the obesity-alleviating effect of SFA at sn-1, 3 positions, these positions were varied among palmitic, stearic and oleic acids, whilst sn-2 position was mainly conserved with oleic acid (Table 2 ). In addition, normalised data, namely gain/feed and fat/feed, were analysed and subcutaneous adiposity and visceral adiposity were used as markers of fat deposition.
Long-chain SFA at sn-1, 3 positions reduce fat deposition Throughout the 15 weeks of the experimental period, there was no discrepancy in the food intake of all the dietary groups, suggesting that all the test oils exerted similar effects on hunger and appetite. In line with previous findings (14) , the diet enriched with HOS (MUFA mainly present at sn-1, 3 positions) was found to cause higher fat deposition than diets with long-chain SFA at similar positions, as observed in the COB, SAL and PMF dietary groups. Furthermore, significantly greater amounts of faecal fatty acids were observed in the latter groups ( Table 4 ), suggesting that the greater excretion of long-chain SFA at sn-1, 3 positions contributed to the lower fat deposition observed. The amount of resynthesised TAG was reduced, affecting their participation in subsequent metabolism and their distribution in tissues and eventually the extent of fat deposition. Therefore, this further validates our postulation, i.e. when long-chain SFA are present at sn-1 and sn-3 positions, the extent of fat deposition will be alleviated. In contrast, the major MUFA, namely oleic acid, was found to be least readily excreted (excretion indices ,1; Table 5 ), as it was well absorbed in the intestine.
Stearic acid at sn-1, 3 positions is more efficient than palmitic acid at sn-1, 3 positions at reducing fat deposition Surprisingly, SAL had been shown to lead to significantly lower gain in body mass as well as visceral and total fat mass compared with PMF, despite their similarity in the positional distribution of long-chain SFA. This observation was concomitant with the significantly higher amounts of faecal NEFA excreted by the SAL dietary group (Table 4) , as well as the relatively higher excretion index of stearic acid in comparison with that of palmitic acid (Table 5 ). In line with the previous literature (25) , the extent of SFA excretion is related to the chain length, i.e. stearic acid is more readily excreted than palmitic acid. Consequently, this phenomenon has been shown to exert a remarkable impact on fat deposition.
When normalised data (fat/feed) were plotted against total SFA content at sn-1, 3 positions (Fig. 1) , the linear correlation as suggested previously (14) was not observed in the present study. Palmitic acid at sn-1, 3 positions, which was the sole major SFA, was responsible for the notable linear correlation observed in the previous study (14) , while in the present study, varying amounts of stearic and palmitic acids at sn-1, 3 positions were employed for comparison. Therefore, a negative linear correlation with exceptional correlation coefficients was only observed when feed efficiency (fat/feed) was correlated with the amount of individual stearic acids at sn-1, 3 positions (Fig. 2) . This suggests that both stearic and palmitic acids exert differential effects on fat absorption and subsequently fat deposition. Data obtained for the HOS dietary group are not shown in Fig. 2 , as the factor affecting fat deposition was the high MUFA content at sn-1, 3 positions. Besides the fatreducing effect of long-chain SFA at sn-1, 3 positions proposed previously (14) , an extended finding is that stearic acid is more efficient at limiting fat deposition than palmitic acid at similar positions.
For efficient intestinal absorption, micelles formed by bile salts transport the non-polar stearic and palmitic acids across the aqueous boundary layer of intestinal wall. The equilibrium between non-polar and aqueous phases and the rate at which the NEFA establish equilibrium between the two phases are crucial for determining the absorption of fatty acids (26) . Poor diffusion of fatty acids into the aqueous phase may inhibit the action of enzymes by blocking the interface. As stearic acid is relatively more apolar than palmitic acid, a lower trend towards intestinal absorption is expected. This has been demonstrated by the remarkably higher amounts of excreted NEFA in the faeces of the SAL dietary group than in that of the PMF dietary group (Table 4) . The reduced absorption of stearic acid will subsequently lead to the reduction of resynthesised TAG levels in chylomicron and their distribution in tissues and eventually the extent of fat deposition. Furthermore, differences in the physio-chemical properties of Ca soaps of fatty acids may give noteworthy insights into their different extent of faecal excretion. For instance, Krafft point for a Ca soap of oleic acid is 318C, for that of palmitic acid is 658C and for that of stearic acid is 828C (27) . Calcium palmitate and calcium stearate are thus solid at body temperature. Consequently, there is no value for the critical micelle concentration as micelles cannot be formed. In general, Krafft points of all the fatty acids are elevated in the presence of Ca ions (27) . Furthermore, the solubility of Ca salt of palmitic acid in water has been reported to be 0·012 mg/l, while a lower extent of dissolution, i.e. 0·0007 mg/l, has been observed for calcium stearate at 258C (28) . Hence, the intestinal absorption of NEFA probably appears to be determined by both hydrophobicity and the Krafft point in aqueous solution. In addition to malabsorption-type effects, the reduced feed efficiency and adiposity observed in the present study may also have occurred as a result of increasing fat oxidation and energy expenditure. Regiospecific analysis of adipose tissue samples (see Supplementary material, available online) indicated a tremendous depreciation of SFA at sn-1, 3 positions (44·1-64·9 mol%), suggesting the lower intestinal absorption of SFA and de novo synthesis by desaturation. In addition, mead acid (20 : 3n-9), which is an indicator for the deficiency of essential fatty acids, was not detected in the subcutaneous as well as visceral adipose tissue samples of mice of all the dietary groups (see Supplementary material, available online). The present study demonstrates that fats predominantly comprised of high amounts of StOSt and POSt, namely SAL and COB, respectively, are associated with lower visceral adiposity. This finding is crucial as visceral adiposity is associated with various diseases, including CVD, insulin resistance, hypertension and overall mortality (29) . Hence, shea butter and mango fat, which contain comparable major TAG species, are expected to exert similar favourable health effects (24) . The observation reported in previous literature (4) that COB is better at preventing fat accretion than palm oil has been successfully elucidated in the present study. Besides this, in our previous work (14) , we observed that dietary oil containing high amounts of linoleic and linolenic acids at sn-1, 3 positions, such as soyabean oil, led to significantly higher fat deposition than the diet enriched with palm olein. With the relatively higher trend exhibited by MUFA and PUFA towards intestinal absorption, diets that contain low amounts of the above-mentioned fatty acids, especially at the sn-1, 3 positions, are expected to lead to a lower risk of body fat deposition. Therefore, we postulate that COB with StOSt and POSt as the major TAG species compared with various food products exhibits a lower tendency to cause obesity and visceral adiposity when compared with highly unsaturated oil products. In conclusion, the encouraging results of the present study may warrant further investigation in human subjects, as well as the synthesis of prospective healthier structured lipids, for instance, 1,3-dibehenoyl-2-oleoylglycerol and 1,3-dilignoceroyl-2-oleoylglycerol, which have the potential to reduce the prevalence of morbid obesity. 
